GlassScriptPhysician profile
Joshua Doangou Lee
NPI 1235700469
$1,207.31
in general payments reported to CMS, 2019-2025
16 companies · $978 in 2025
The $978 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $229 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $211.44 | 2024-2025 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $151.00 | 2025 | |
| Ucb, INC. | $146.74 | 2025 | Bimzelx |
| Novo Nordisk INC | $144.97 | 2024-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.87 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $88.14 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $80.53 | 2024-2025 | Verquvo |
| Pfizer INC. | $58.19 | 2025 | |
| Dexcom, INC. | $49.11 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $28.54 | 2025 | Evenity |
| Otsuka America Pharmaceutical, INC. | $26.10 | 2025 | Rexulti |
| Vivus LLC | $23.60 | 2025 | Pancreaze |
| Exact Sciences Corporation | $22.57 | 2025 | Cologuard Collection Kit |
| Radius Health, INC. | $21.76 | 2025 | Tymlos |
| Abbvie INC. | $20.82 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.